Literature DB >> 12596049

Founder effect of the C9 R95X mutation in Orientals.

Vahid Khajoee1, Kenji Ihara, Ryutaro Kira, Megumi Takemoto, Hiroyuki Torisu, Yasunari Sakai, Jia Guanjun, Park Myoung Hee, Katsushi Tokunaga, Toshiro Hara.   

Abstract

A nonsense mutation at codon 95 (R95X) in the C9 gene is responsible for most Japanese C9 deficiency (C9D) cases, with a carrier frequency of 6.7%. Upon analysis of microsatellite markers and newly identified dinucleotide repeat number polymorphisms in the 3' flanking region of the C9 gene, a founder effect was demonstrated for the R95X mutation of the C9 gene in Japanese. Screening for the R95X mutation in Korean and Chinese individuals showed that the R95X carrier frequencies in Koreans and Chinese were 2.0% and 1.0%, respectively. Although homozygotes for the R95X mutation were not found in Korea or China, the shared haplotype of the dinucleotide repeat number polymorphisms appeared to be associated with the R95X mutation in the heterozygotes in Korea and China. The founder effect found in East Asians (Japanese, Koreans and Chinese) but not in Caucasians, as well as the haplotype sharing in only a small chromosomal interval, suggested that the R95X mutation of C9 gene was ancient and had occurred after the divergence of East Asians and Caucasians, and before migration of the Yayoi people to Japan. Since the mortality of meningococcal infections in complement-deficient patients is lower than that in normal individuals, a founder effect and a selective advantage in isolation might be the main reasons for the high frequency of the R95X mutation in Japan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12596049     DOI: 10.1007/s00439-002-0870-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Genetic clues revise view of Japanese roots.

Authors:  D Normile
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

2.  Delineation of additional genetic bases for C8 beta deficiency. Prevalence of null alleles and predominance of C-->T transition in their genesis.

Authors:  L Saucedo; L Ackermann; A E Platonov; A Gewurz; R M Rakita; P Densen
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

Review 3.  Characteristics of Mongoloid and neighboring populations based on the genetic markers of human immunoglobulins.

Authors:  H Matsumoto
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

Review 4.  The Fukuyama congenital muscular dystrophy story.

Authors:  T Toda; K Kobayashi; E Kondo-Iida; J Sasaki; Y Nakamura
Journal:  Neuromuscul Disord       Date:  2000-03       Impact factor: 4.296

5.  A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese.

Authors:  T Horiuchi; H Nishizaka; T Kojima; T Sawabe; Y Niho; P M Schneider; S Inaba; K Sakai; K Hayashi; C Hashimura; Y Fukumori
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

Review 6.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

7.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

8.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

9.  High-incidence of C9 deficiency throughout Japan: there are no significant differences in incidence among eight areas of Japan.

Authors:  K Hayama; N Sugai; S Tanaka; S Lee; H Kikuchi; J Ito; J Suzuki; Y Nagata; H Kondo; O Harayama
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

10.  Heterogeneity in the genetic basis of human complement C9 deficiency.

Authors:  K Witzel-Schlömp; M J Hobart; B A Fernie; A Orren; R Würzner; C Rittner; T Kaufmann; P M Schneider
Journal:  Immunogenetics       Date:  1998-07       Impact factor: 2.846

View more
  6 in total

Review 1.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 2.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

3.  Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.

Authors:  Bridget Charbonneau; Matthew J Maurer; Zachary S Fredericksen; Clive S Zent; Brian K Link; Anne J Novak; Stephen M Ansell; George J Weiner; Alice H Wang; Thomas E Witzig; Ahmet Dogan; Susan L Slager; Thomas M Habermann; James R Cerhan
Journal:  Am J Hematol       Date:  2012-06-20       Impact factor: 10.047

4.  Novel pathogenic mutations identified in the first Chinese pedigree of complete C6 deficiency.

Authors:  Philip H Li; William Wy Wong; Evelyn Ny Leung; Chak-Sing Lau; Elaine Au
Journal:  Clin Transl Immunology       Date:  2020-07-08

5.  Evidence of a founder effect for the 235delC mutation of GJB2 (connexin 26) in east Asians.

Authors:  Denise Yan; Hong-Joon Park; Xiao Mei Ouyang; Arti Pandya; Katsumi Doi; Raadnabazar Erdenetungalag; Li Lin Du; Naoki Matsushiro; Walter E Nance; Andrew J Griffith; Xue Zhong Liu
Journal:  Hum Genet       Date:  2003-09-18       Impact factor: 4.132

Review 6.  To Kill But Not Be Killed: Controlling the Activity of Mammalian Pore-Forming Proteins.

Authors:  Patrycja A Krawczyk; Marco Laub; Patrycja Kozik
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.